Features
Sickle Cell Disease (SCD) is the UK’s fastest growing genetic condition, with almost 300 babies born with SCD each year. However, with the MHRA’s recent withdrawal of marketing authorisation for pioneering new treatment Crizanlizumab, there remains just one treatment - hydroxyurea - that is licensed and approved by the NHS for patients. Fundamentally, over the [...]
Anne Lepetit, Chief Medical Officer, Bupa Group
By the Fearsome team
By Roberta Sher, Assistant, Isabel Valdes, Assistant, Ben Hipwell, Associate at Intellectual Property Law Firm, Reddie & Grose
By TidalSense CEO, Dr Ameera Patel
Cell and gene therapies are advancing at a rapid rate, but huge costs and time-consuming manual manufacturing processes are keeping therapies out of reach for most patients. Ori Biotech is on a mission to change the landscape. Cell and gene therapy is revolutionising the way cancer and rare diseases are treated. The process is highly [...]
By Pamela James, Ph.D., Vice President, Product, Vector Laboratories
By Sofie McPherson, Patent Director, HGF
Your path to more affordable & accessible online behavioural health care
Major heart surgery and chronic pain left Zach Gotlib craving meaningful connection with people who could relate what he was going through. He tells Health Tech World about the ‘selfish’ reasons behind the creation of SelfiHealth, an app that tackles social isolation through peer-to-peer health support. Born with a congenital heart defect, Zach Gotlib was [...]
